Orbit Discovery
Orbit Discovery specialises in identifying novel peptide and scaffold modulators of GPCRs and other membrane targets. Our high-throughput microfluidic platform screens libraries of millions of peptides directly in functional cell assays, enabling rapid identification of agonists and antagonists. Combined with FACS-based binding screens, Orbit delivers highly selective modulators to accelerate GPCR drug discovery with its biotech and pharma partners.
